Skip to content
Rottendorf Pharma logo — company profile

Rottendorf Pharma

Founded 1928 Germany Ennigerloh, Germany 411 employees Biopharma, Biotechnology +1

General Information

Company Name Rottendorf Pharma
Founded Year 1928
Location Germany Ennigerloh, Germany
Employees 411
Industries Biopharma, Biotechnology, Manufacturing
Social

BounceWatch is an independent company data service, not affiliated with Rottendorf Pharma. To contact Rottendorf Pharma, visit rottendorf.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rottendorf Pharma compare?

A PDF of Rottendorf Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rottendorf Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Rottendorf Pharma

Rottendorf Pharma, established in 1928, is a leading Contract Development and Manufacturing Organization (CDMO) in the biopharma, biotechnology, and manufacturing industries. With a focus on solid oral dosage forms, the company has over 95 years of experience in manufacturing, packaging, and developing formulations and analytical methods. Rottendorf Pharma's extensive portfolio includes over 600 originator and generic drug products annually, serving a diverse clientele, from big pharmaceutical companies to small, virtual, and global biotechnology firms. The company follows the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), positioning itself as an extension of its clients' organizations. This approach allows Rottendorf Pharma to optimize solid dosage form production, leveraging its expertise for the benefit of its customers. Notably, Rottendorf Pharma does not market its own product brands or hold any product licenses, ensuring that it does not compete with its clients in the pharmaceutical market. With a proven track record of nearly a century, Rottendorf Pharma presents a compelling opportunity for investment in the CDMO sector, offering expertise, reliability, and a client-focused approach for potential venture capital partners.

No funding data available for Rottendorf Pharma yet.

Rottendorf Pharma Alternatives & Competitors

Rottendorf Pharma vs
Mikart, LLC
Mikart, LLC United States

Solid Foundation Flexible Solutions

161 employees
Biotechnology, Manufacturing
Rottendorf Pharma vs

Working Today For A Healthier Tomorrow

Private Equity
1055 employees
Biotechnology, Manufacturing
Rottendorf Pharma vs

Fostering Value through Innovation

155 employees
Biotechnology, Manufacturing

FAQ About Rottendorf Pharma

A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 95 years. The company produces more than 600...
Rottendorf Pharma was founded in 1928.
Rottendorf Pharma is headquartered in Ennigerloh, Germany.
Rottendorf Pharma operates in Biopharma, Biotechnology and Manufacturing.
Rottendorf Pharma has approximately 411 employees.
Top alternatives and competitors to Rottendorf Pharma include Mikart, LLC, Macter International Limited, Cerbios-Pharma SA, CMAB Biopharma, Catalent. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rottendorf Pharma and Mikart, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rottendorf Pharma, https://bouncewatch.com/company/rottendorf-pharma, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout